165 related articles for article (PubMed ID: 24626568)
1. Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon.
Uekusa S; Kawashima H; Sugito K; Yoshizawa S; Shinojima Y; Igarashi J; Ghosh S; Wang X; Fujiwara K; Ikeda T; Koshinaga T; Soma M; Nagase H
Int J Oncol; 2014 May; 44(5):1669-77. PubMed ID: 24626568
[TBL] [Abstract][Full Text] [Related]
2. DNA hypomethylation at the ZNF206-exon 5 CpG island associated with neuronal differentiation in mice and development of neuroblastoma in humans.
Kawashima H; Sugito K; Yoshizawa S; Uekusa S; Furuya T; Ikeda T; Koshinaga T; Shinojima Y; Hasegawa R; Mishra R; Igarashi J; Kimura M; Wang X; Fujiwara K; Gosh S; Nagase H
Int J Oncol; 2012 Jan; 40(1):31-9. PubMed ID: 22011711
[TBL] [Abstract][Full Text] [Related]
3. Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells.
Hirano T; Nagasaki-Maeoka E; Ishizuka Y; Takatori A; Watanabe Y; Hoshi R; Yoshizawa S; Kawashima H; Uekusa S; Sugito K; Uehara S; Fukuda N; Nagase H; Takayama T; Soma M; Koshinaga T; Fujiwara K
Med Oncol; 2019 Jun; 36(8):66. PubMed ID: 31183633
[TBL] [Abstract][Full Text] [Related]
4. Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.
Shimizu R; Muto T; Aoyama K; Choi K; Takeuchi M; Koide S; Hasegawa N; Isshiki Y; Togasaki E; Kawajiri-Manako C; Nagao Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Iseki T; Starczynowski DT; Iwama A; Yokote K; Nakaseko C
Leuk Res; 2016 Nov; 50():85-94. PubMed ID: 27697661
[TBL] [Abstract][Full Text] [Related]
5. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
[TBL] [Abstract][Full Text] [Related]
6. The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells.
Nagaoka M; Yashiro T; Uchida Y; Ando T; Hara M; Arai H; Ogawa H; Okumura K; Kasakura K; Nishiyama C
J Immunol; 2017 Oct; 199(8):2958-2967. PubMed ID: 28893954
[TBL] [Abstract][Full Text] [Related]
7. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
[TBL] [Abstract][Full Text] [Related]
9. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
10. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development.
Liang P; Song F; Ghosh S; Morien E; Qin M; Mahmood S; Fujiwara K; Igarashi J; Nagase H; Held WA
BMC Genomics; 2011 May; 12(1):231. PubMed ID: 21569359
[TBL] [Abstract][Full Text] [Related]
12. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
Alaminos M; Davalos V; Cheung NK; Gerald WL; Esteller M
J Natl Cancer Inst; 2004 Aug; 96(16):1208-19. PubMed ID: 15316056
[TBL] [Abstract][Full Text] [Related]
13. Elevation of NR4A3 expression and its possible role in modulating insulin expression in the pancreatic beta cell.
Gao W; Fu Y; Yu C; Wang S; Zhang Y; Zong C; Xu T; Liu Y; Li X; Wang X
PLoS One; 2014; 9(3):e91462. PubMed ID: 24638142
[TBL] [Abstract][Full Text] [Related]
14. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
Djos A; Martinsson T; Kogner P; Carén H
Mol Cancer; 2012 Jun; 11():40. PubMed ID: 22695170
[TBL] [Abstract][Full Text] [Related]
15. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
16. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
Casalà C; Gil-Guiñón E; Ordóñez JL; Miguel-Queralt S; Rodríguez E; Galván P; Lavarino C; Munell F; de Alava E; Mora J; de Torres C
Carcinogenesis; 2013 Feb; 34(2):268-76. PubMed ID: 23108190
[TBL] [Abstract][Full Text] [Related]
17. The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
Wenzl K; Troppan K; Neumeister P; Deutsch AJ
Curr Drug Targets; 2015; 16(1):38-46. PubMed ID: 25410408
[TBL] [Abstract][Full Text] [Related]
18. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.
Fujiwara K; Ghosh S; Liang P; Morien E; Soma M; Nagase H
Mol Carcinog; 2015 Mar; 54(3):178-88. PubMed ID: 24115114
[TBL] [Abstract][Full Text] [Related]
20. Co-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma.
Murphy DM; Buckley PG; Das S; Watters KM; Bryan K; Stallings RL
PLoS One; 2011; 6(6):e21436. PubMed ID: 21731748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
